Greenleaf Trust Buys New Position in HealthEquity, Inc. (NASDAQ:HQY)

Greenleaf Trust bought a new stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 2,232 shares of the company's stock, valued at approximately $214,000.

Several other hedge funds have also recently added to or reduced their stakes in the company. KBC Group NV boosted its holdings in HealthEquity by 56.7% during the 4th quarter. KBC Group NV now owns 3,860 shares of the company's stock valued at $370,000 after acquiring an additional 1,397 shares during the period. Curated Wealth Partners LLC bought a new stake in shares of HealthEquity in the fourth quarter worth about $242,000. Exchange Traded Concepts LLC lifted its holdings in HealthEquity by 2.6% in the 4th quarter. Exchange Traded Concepts LLC now owns 9,813 shares of the company's stock worth $942,000 after buying an additional 245 shares during the period. Janney Montgomery Scott LLC lifted its holdings in HealthEquity by 8.5% in the 4th quarter. Janney Montgomery Scott LLC now owns 5,352 shares of the company's stock worth $514,000 after buying an additional 420 shares during the period. Finally, Nisa Investment Advisors LLC grew its position in shares of HealthEquity by 8.7% in the 4th quarter. Nisa Investment Advisors LLC now owns 3,719 shares of the company's stock worth $357,000 after buying an additional 299 shares during the last quarter. Institutional investors own 99.55% of the company's stock.

HealthEquity Stock Up 0.6 %

HealthEquity stock traded up $0.63 during mid-day trading on Monday, hitting $112.15. The company had a trading volume of 584,732 shares, compared to its average volume of 743,724. HealthEquity, Inc. has a 12 month low of $65.01 and a 12 month high of $113.61. The company has a market capitalization of $9.72 billion, a PE ratio of 102.89, a price-to-earnings-growth ratio of 1.61 and a beta of 0.55. The stock's 50 day moving average price is $101.18 and its two-hundred day moving average price is $89.98. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51.

HealthEquity (NASDAQ:HQY - Get Free Report) last announced its quarterly earnings results on Monday, December 9th. The company reported $0.59 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same quarter in the prior year, the firm posted $0.40 earnings per share. As a group, sell-side analysts anticipate that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Insider Activity

In other news, Director Robert W. Selander sold 8,250 shares of the firm's stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $101.56, for a total transaction of $837,870.00. Following the sale, the director now owns 66,469 shares of the company's stock, valued at $6,750,591.64. This trade represents a 11.04 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Stuart B. Parker sold 25,000 shares of HealthEquity stock in a transaction that occurred on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the completion of the sale, the director now owns 19,061 shares of the company's stock, valued at $1,843,579.92. This represents a 56.74 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 2.20% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts recently commented on HQY shares. Royal Bank of Canada raised their price target on HealthEquity from $100.00 to $105.00 and gave the stock an "outperform" rating in a research note on Tuesday, December 10th. BTIG Research lifted their target price on shares of HealthEquity from $110.00 to $130.00 and gave the company a "buy" rating in a research note on Thursday, November 14th. Bank of America increased their price target on shares of HealthEquity from $100.00 to $120.00 and gave the stock a "buy" rating in a research note on Wednesday, November 13th. Barrington Research raised their price objective on shares of HealthEquity from $105.00 to $120.00 and gave the stock an "outperform" rating in a report on Monday, December 2nd. Finally, JMP Securities upped their target price on HealthEquity from $105.00 to $107.00 and gave the stock a "market outperform" rating in a report on Tuesday, December 10th. One analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $110.71.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.